Expert Interview
DIgging into the Phase 1 Data of CRISPR therapeutics' CTX310 gene therapy for cardiovascular disease.
Ticker(s): CRSPInstitution: Oregon Health & Science University
- Associate Director of the Center for Preventive Cardiology and Professor at Oregon Health & Science University with a specific clinical focus on inherited lipid disorders.
- Personally manages ~500 patients with HeFH within the center for Preventive Cardiology.
- Research focuses on PCSK9 physiology and its impact on lipoprotein metabolism; engaged in clinical trials testing novel lipid modulating therapeutics.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
